- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03597542
Examining the Relationship Between Acute Meal Intake and Inflammation in Children
July 28, 2018 updated by: Naiman Khan, University of Illinois at Urbana-Champaign
Recent evidence has shown that obese and overweight children exhibit states of chronic inflammation.
In obese adults, a high carbohydrate meal induces an inflammatory response; however, the effects of a high carbohydrate meal on biomarkers of inflammation has not previously been examined in children.
The purpose of this research project is to characterize the inflammatory response to a high carbohydrate versus a low carbohydrate meal in healthy weight, overweight, and obese children (age 7-17 years).
After completing informed consent/assent, a Dual-energy X-ray Absorptiometry (DXA) scan, and baseline blood draw on experimental day 1, children will then return to the lab two times to ingest either a high or low carbohydrate beverage followed by post-meal blood collection for a total of 3 blood draws.
Biomarkers of inflammation will be analyzed by flow cytometry and enzyme-linked immunosorbent assay (ELISA).
Participants will be recruited through various studies through the Neurocognitive Kinesiology Lab/Body Composition and Nutritional Neuroscience Labs as well as through the local Champaign-Urbana community.
Data from this project will provide a better understanding of the inflammatory response to different meals in healthy weight, overweight, and obese children.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Urbana, Illinois, United States, 61801
- University of Illinois at Urbana-Champaign
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
7 years to 17 years (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
• Between the ages of 7-17
Exclusion Criteria:
- Younger than 7 years and older than 17 years
- Presence of allergies to eggs and/or sugar substitutes
- Presence of heart or respiratory disease
- Presence of uncontrolled hypertension, diabetes
- Use of anti-inflammatory medications
- Presence of cancer or metabolic disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Maltodextrin
Participants will consume 56g of maltodextrin dissolved in 500mL of water.
|
Participants are asked to consume both egg based powder or maltodextrin dissolved in 500mL of water at two different time points at least one week apart.
Participants will then submit to a venous blood draw to assess levels of cellular inflammation.
|
Experimental: Egg
Participants will consume 36g of spray-dried egg powder (equivalent to 3 eggs) dissolved in 500mL of water.
|
Participants are asked to consume both egg based powder or maltodextrin dissolved in 500mL of water at two different time points at least one week apart.
Participants will then submit to a venous blood draw to assess levels of cellular inflammation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effects of egg or maltodextrin on inflammatory cytokines (Tumor necrosis factor-alpha, C-reactive protein, and Interleukin-6)
Time Frame: 3 weeks.
|
Will be used by determining any changes in inflammatory cytokines via enzyme-linked immunosorbent assay (ELISA) kits.
|
3 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effects of egg or maltodextrin on inflammatory monocyte cells with and without expression of Toll-like receptor 4 and C-C Chemokine receptor-2.
Time Frame: 3 weeks.
|
Will be used by determining the cells per microliter of lysed whole blood.
|
3 weeks.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 29, 2017
Primary Completion (Actual)
February 2, 2018
Study Completion (Actual)
February 2, 2018
Study Registration Dates
First Submitted
July 13, 2018
First Submitted That Met QC Criteria
July 13, 2018
First Posted (Actual)
July 24, 2018
Study Record Updates
Last Update Posted (Actual)
July 31, 2018
Last Update Submitted That Met QC Criteria
July 28, 2018
Last Verified
July 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17112
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inflammation
-
University of EdinburghUmeå UniversityCompletedSystemic Inflammation | Respiratory InflammationSweden
-
University of AarhusAarhus University Hospital; University of CopenhagenCompletedSystemic Inflammation | Airway InflammationDenmark
-
Sykehuset TelemarkRikshospitalet University Hospital; Helse Sor-OstCompletedAirway Inflammation | Peripheral Blood Inflammation Markers | Cement Dust ExposureNorway
-
Assistance Publique - Hôpitaux de ParisCompletedDigestive InflammationFrance
-
Pamukkale UniversityCompletedPeriodontal InflammationTurkey
-
Universidade Federal do ParaCompleted
-
KLE Society's Institute of Dental SciencesCompletedRegenerative InflammationIndia
-
Fondation Ophtalmologique Adolphe de RothschildCompleted
-
Singapore National Eye CentreCompletedIntraocular Inflammation in ChildrenSingapore
Clinical Trials on Eggs and Carbohydrates
-
Ahmad Hussieny SalamaCompleted
-
Norwegian University of Science and TechnologyCompleted
-
Michael A. NauckCompleted
-
North-West University, South AfricaActive, not recruitingLinear GrowthSouth Africa
-
University of ConnecticutCompleted
-
Tufts UniversityAmerican Egg BoardCompleted
-
Josip Juraj Strossmayer University of OsijekUnknownOmega-3 Polyunsaturated Fatty AcidsCroatia
-
Nutricia ResearchCompletedPostprandial HypoglycemiaNetherlands
-
University of AarhusCompletedCrohn Disease | Ulcerative Colitis | Intestinal Helminthiasis
-
University of AarhusCompletedCrohn Disease | Colitis, Ulcerative | Intestinal Helminthiasis